Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform! We are thrilled to announce the publication of our paper, ” An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers,” in the prestigious Advanced Science journal. Led by Dr. Hsing-Mao Chu, CEO of T-E Meds, this research … Continue reading Our latest research result is published in Advanced Science